Clinical Trial

Impact of Dietary Guidance and Probiotics in the Treatment of Endometriosis and Irritable Bowel Syndrome in Women

Recruiting
View on ClinicalTrials.gov →
Summary
Patients with endometriosis are 2 to 3 times more likely to develop Irritable Bowel Syndrome (IBS) than women without the condition. IBS presents symptoms similar to those of intestinal and deep EDT, leading to diagnostic errors and delays in identifying such comorbidities. Diets have shown positive effects on symptoms in women with both conditions, supporting the theory of a similar pathophysiology. The investigators goal is to examine how dietary practices and probiotic use affect chronic pelvic pain in patients with both comorbidities.
Trial Details
NCT Number NCT07149519
Lead Sponsor University of Sao Paulo
Conditions Endometriosis, Bowels Irritable
Enrollment 74 participants
Start Date 2025-03-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2029-02-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-02